Pfizer ends study on potential lung cancer drug Pharmaceutical Processing "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug TheNewsTribune.com "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug Marin Independent-Journal "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer cancels phase III study of lung cancer drug Zenopa The company acted on an independent recommendation that the drug, which is a treatment for non-adenocarcinoma non-small cell lung cancer, was unlikely to ...
Pfizer says Sutent breast cancer trials fail Alibaba News Channel Pfizer said outside monitors concluded that the Phase 3 trial of figitumumab in patients with previously treated advanced non-small cell lung cancer was ...
Banking on a breakthrough The Australian Sometimes we get it wrong, but in this case I believe chances are pretty small that there won't be uses for [cord blood]." Regardless, Australian Stem Cell ...
Pfizer Ends Study On Potential Lung Cancer Drug CBS News "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug FederalNewsRadio.com "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Avastin Misses Prostrate-Cancer Goal Wall Street Journal Avastin, an antibody, is approved in the US and Europe for the treatment of advanced stages of colorectal cancer, breast cancer, non-small cell lung cancer ...
Pfizer ends study on potential lung cancer drug Fort Wayne Journal Gazette "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug SunHerald.com (press release) "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer ends study on potential lung cancer drug BlueRidgeNow.com "This outcome is disappointing to us and to patients with non-small cell lung cancer," said Dr. Mace Rothenberg, senior vice president of clinical ...
